Antimicrobial Agents and Chemotherapy · 2003 · 21 citations · 43 references
MedicineInfectious DiseasesPharmacologyImmunology Of Infectious DiseasesMolecular VirologyVirologyAntiretroviral TherapyAntiviral AgentsAntiviral PharmacologyAntiviral PharmacotherapyAntiviral TherapyEnzyme InhibitionAntiretroviral Drug ClassesAntiviral Susceptibility TestingDrug Susceptibility AssaysHiv Antiretroviral TherapyHiv SusceptibilityNon-nucleoside Reverse Transcriptase InhibitorsPharmacodynamics Of Antiretroviral TherapyViral Protease Inhibition
We used a focal infectivity assay with HeLa H1-JC.37 cells to directly compare susceptibilities of simian immunodeficiency virus (SIV) and human immunodeficiency virus type 1 (HIV-1) to protease inhibitors. SIVmac239 was inhibited by indinavir, saquinavir, and ritonavir, with 50% effective concentrations (means +/- standard deviations) of 39 +/- 8, 55 +/- 3, and 13 +/- 5 nM, respectively. The corresponding values for inhibition of HIV-1 were 66 +/- 4, 47 +/- 10, and 25 +/- 14 nM, respectively.
43
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
David D. Ho, Avidan U. Neumann, Alan S. Perelson et al. · Nature · 1995 · 4.3K citations
Scott M. Hammer, Kathleen Squires, Michael D. Hughes et al. · New England Journal of Medicine · 1997 · 2.7K citations · Full text